All Updates

All Updates

icon
Filter
Partnerships
Caris Life Sciences partners with ConcertAI to create clinico-genomic platform
Precision Medicine
Jun 1, 2023
This week:
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Funding
OceanWell raises USD 11 million in Series A funding to build water farms
Conservation Tech
Yesterday
Product updates
H launches Runner H, an AI agent for business automation
Foundation Models
Yesterday
Partnerships
Capgemini partners with Mistral AI and Microsoft to expand GenAI solutions globally
Foundation Models
Yesterday
Funding
Product updates
Converge Bio launches biotech LLM platform with USD 5.5 million seed funding
Foundation Models
Yesterday
Partnerships
Snowflake partners with Anthropic to integrate Claude AI models into Cortex AI platform
Foundation Models
Yesterday
Product updates
DeepSeek releases AI reasoning model DeepSeek-R1
Foundation Models
Yesterday
Industry news
Partnerships
ICEYE partners with Lockheed Martin and Finnish firms to develop defense space technologies
Next-gen Satellites
Yesterday
Partnerships
Dematic installs AutoStore system at South West Healthcare logistics hub
Logistics Tech
Yesterday
Precision Medicine

Precision Medicine

Jun 1, 2023

Caris Life Sciences partners with ConcertAI to create clinico-genomic platform

Partnerships

  • Molecular profiling company Caris Life Sciences and AI-powered data solutions provider ConcertAI have announced an extension to their original partnership (which was initially announced in January 2023) to create a clinico-genomic platform.

  • The partnership aims to generate a comprehensive database of molecular and clinical data that will provide insights for precision medicine, therapeutic development, and clinical trial management. The initiative will enable multi-year programs focused on specific cancers and molecular targets, supporting translational sciences, clinical development, and post-approval evidence generation leveraging ConcertAI's clinical data and Caris' molecular profiling capabilities. 

  • The partnership involves aligning clinical trial networks, patient identification and matching solutions, scientific talent, and AI technologies. The initiative will facilitate access to large-scale, integrated data and technologies, accelerating research, and benefiting cancer patients with limited therapeutic options by providing access to comprehensive and extensive data for improved patient care.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.